144 related articles for article (PubMed ID: 25747044)
1. Novel patented therapeutic approaches targeting the 37/67 kDa laminin receptor for treatment of cancer and Alzheimer's disease.
Jovanovic K; Chetty CJ; Khumalo T; Da Costa Dias B; Ferreira E; Malindisa ST; Caveney R; Letsolo BT; Weiss SF
Expert Opin Ther Pat; 2015 May; 25(5):567-82. PubMed ID: 25747044
[TBL] [Abstract][Full Text] [Related]
2. Patented therapeutic approaches targeting LRP/LR for cancer treatment.
Vania L; Morris G; Otgaar TC; Bignoux MJ; Bernert M; Burns J; Gabathuse A; Singh E; Ferreira E; Weiss SFT
Expert Opin Ther Pat; 2019 Dec; 29(12):987-1009. PubMed ID: 31722579
[No Abstract] [Full Text] [Related]
3. Patented biological approaches for the therapeutic modulation of the 37 kDa/67 kDa laminin receptor.
Omar A; Jovanovic K; Da Costa Dias B; Gonsalves D; Moodley K; Caveney R; Mbazima V; Weiss SF
Expert Opin Ther Pat; 2011 Jan; 21(1):35-53. PubMed ID: 21110766
[TBL] [Abstract][Full Text] [Related]
4. Invasion of tumorigenic HT1080 cells is impeded by blocking or downregulating the 37-kDa/67-kDa laminin receptor.
Zuber C; Knackmuss S; Zemora G; Reusch U; Vlasova E; Diehl D; Mick V; Hoffmann K; Nikles D; Fröhlich T; Arnold GJ; Brenig B; Wolf E; Lahm H; Little M; Weiss S
J Mol Biol; 2008 May; 378(3):530-9. PubMed ID: 18387633
[TBL] [Abstract][Full Text] [Related]
5. Knock-Down of the 37kDa/67kDa Laminin Receptor LRP/LR Impedes Telomerase Activity.
Naidoo K; Malindisa ST; Otgaar TC; Bernert M; Da Costa Dias B; Ferreira E; Reusch U; Knackmuss S; Little M; Weiss SF; Letsolo BT
PLoS One; 2015; 10(11):e0141618. PubMed ID: 26545108
[TBL] [Abstract][Full Text] [Related]
6. Knock-down of LRP/LR promotes apoptosis in early and late stage colorectal carcinoma cells via caspase activation.
Vania L; Rebelo TM; Ferreira E; Weiss SFT
BMC Cancer; 2018 May; 18(1):602. PubMed ID: 29843646
[TBL] [Abstract][Full Text] [Related]
7. The 37kDa/67kDa laminin receptor acts as a receptor for Aβ42 internalization.
Da Costa Dias B; Jovanovic K; Gonsalves D; Moodley K; Reusch U; Knackmuss S; Weinberg MS; Little M; Weiss SF
Sci Rep; 2014 Jul; 4():5556. PubMed ID: 24990253
[TBL] [Abstract][Full Text] [Related]
8. Anti-LRP/LR-specific antibody IgG1-iS18 impedes adhesion and invasion of pancreatic cancer and neuroblastoma cells.
Rebelo TM; Chetty CJ; Ferreira E; Weiss SF
BMC Cancer; 2016 Nov; 16(1):917. PubMed ID: 27884119
[TBL] [Abstract][Full Text] [Related]
9. LRP/LR as an alternative promising target in therapy of prion diseases, Alzheimer's disease and cancer.
Vana K; Zuber C; Pflanz H; Kolodziejczak D; Zemora G; Bergmann AK; Weiss S
Infect Disord Drug Targets; 2009 Feb; 9(1):69-80. PubMed ID: 19200017
[TBL] [Abstract][Full Text] [Related]
10. Anti-LRP/LR-specific antibody IgG1-iS18 significantly reduces adhesion and invasion of metastatic lung, cervix, colon and prostate cancer cells.
Omar A; Reusch U; Knackmuss S; Little M; Weiss SF
J Mol Biol; 2012 May; 419(1-2):102-9. PubMed ID: 22391421
[TBL] [Abstract][Full Text] [Related]
11. LRP::FLAG Rescues Cells from Amyloid-β-Mediated Cytotoxicity Through Increased TERT Levels and Telomerase Activity.
Bignoux MJ; Cuttler K; Otgaar TC; Ferreira E; Letsolo BT; Weiss SFT
J Alzheimers Dis; 2019; 69(3):729-741. PubMed ID: 31081791
[TBL] [Abstract][Full Text] [Related]
12. Interactions between PrP(c) and other ligands with the 37-kDa/67-kDa laminin receptor.
Mbazima V; Da Costa Dias B; Omar A; Jovanovic K; Weiss SF
Front Biosci (Landmark Ed); 2010 Jun; 15(3):1150-63. PubMed ID: 20515747
[TBL] [Abstract][Full Text] [Related]
13. Discovery of new small molecules inhibiting 67 kDa laminin receptor interaction with laminin and cancer cell invasion.
Pesapane A; Di Giovanni C; Rossi FW; Alfano D; Formisano L; Ragno P; Selleri C; Montuori N; Lavecchia A
Oncotarget; 2015 Jul; 6(20):18116-33. PubMed ID: 26062445
[TBL] [Abstract][Full Text] [Related]
14. Variable levels of 37-kDa/67-kDa laminin receptor (RPSA) mRNA in ovine tissues: potential contribution to the regulatory processes of PrPSc propagation?
Qiao JW; Su XO; Li YX; Yang JM; Wang YQ; Kouadir M; Zhou XM; Yang LF; Yin XM; Zhao DM
Anim Biotechnol; 2009; 20(3):151-5. PubMed ID: 19544211
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of LRP/LR Induces Apoptosis in Breast and Oesophageal Cancer Cells.
Khumalo T; Ferreira E; Jovanovic K; Veale RB; Weiss SF
PLoS One; 2015; 10(10):e0139584. PubMed ID: 26427016
[TBL] [Abstract][Full Text] [Related]
16. Knock-down of LRP/LR influences signalling pathways in late-stage colorectal carcinoma cells.
Vania L; Morris G; Ferreira E; Weiss SFT
BMC Cancer; 2021 Apr; 21(1):392. PubMed ID: 33836696
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of LRP/LR with siRNA inhibits several cancer hallmarks in lung cancer cells.
Bignoux MJ; Otgaar TC; Bernert M; Weiss SFT; Ferreira E
FEBS Open Bio; 2023 Feb; 13(2):323-340. PubMed ID: 36579897
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of the non-integrin laminin receptor reduces cellular viability by inducing apoptosis in lung and cervical cancer cells.
Moodley K; Weiss SF
PLoS One; 2013; 8(3):e57409. PubMed ID: 23472084
[TBL] [Abstract][Full Text] [Related]
19. IgG1-iS18 impedes the adhesive and invasive potential of early and late stage malignant melanoma cells.
Munien C; Rebelo TM; Ferreira E; Weiss SF
Exp Cell Res; 2017 Feb; 351(2):135-141. PubMed ID: 28118986
[TBL] [Abstract][Full Text] [Related]
20. Cellular prion protein/laminin receptor: distribution in adult central nervous system and characterization of an isoform associated with a subtype of cortical neurons.
Baloui H; von Boxberg Y; Vinh J; Weiss S; Rossier J; Nothias F; Stettler O
Eur J Neurosci; 2004 Nov; 20(10):2605-16. PubMed ID: 15548204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
